Organ-on-Chip Market Trends, Share, Key Players and Forecast Report

The major drivers for the organ-on-chip market are government funding and support, increasing demand for the discovery and development of effective drugs, concerns with respect to drug testing on animals, and rise in the number of drug repurpose approaches. Generating a revenue of $11.0 million in 2017, the sales of such products are expected to value $163.1 million by 2025, witnessing a CAGR of 40.1% during 2018-2025 (forecast period). The term refers to extremely small cell culture chips with microfluidic channels, which simulate the workings of real human cells and tissues.

Download sample copy off this report@ https://www.psmarketresearch.com/market-analysis/organ-on-chip-market/report-sample

When segmented by type, the market is categorized into liver, lung, kidney, heart, intestine, brain, and others; others include bone marrow, artery, blood-brain barrier, and skin. Among these, the liver category dominated the organ-on-chip market in 2017, as a result of the rising cases of hepatic diseases, such as liver cancer, hepatic fibrosis, cirrhosis, and hepatitis, and the need for effective drugs. Even during the forecast period, it is projected to witness the highest CAGR, of 46.1%.

The market is also expanding owing to the rising need to stop drug testing on animals. As animal cells are different than human cells, testing medicines on them does not always give accurate results. Therefore, the need to gain precise results, without having to test drugs on humans during the initial development stages, is leading to a swift rise in the usage of organ-on-chips by pharmaceutical companies and research institutes.

Pre-Purchase Inquiry at@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=organ-on-chip-market

Globally, North America held the largest share in the organ-on-chip market, with the U.S. as the larger revenue contributor, in 2017. This was due to the robust government support for technological research and development (R&D) and heavy investments by major pharma firms in the field. Asia-Pacific (APAC) is expected to witness the fastest progress in the industry, owing to the surging number of government initiative for R&D, escalating healthcare expenditure, and rising usage of advanced technologies.

Hence, as the requirement for cost-effective and fast drug delivery process increases, so would the adoption of organ-on-chips.

Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: http://psintelligence.blogspot.com/

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.